Knott David M Jr »

Ultragenyx Pharmaceutical shares owned by Knott David M Jr

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 52k 30.08
2025-06-30 $1.9M 52k 36.36
2025-03-31 $1.7M 48k 36.21

More positions owned by Knott David M Jr

Calumet Common (CLMT)
Apollo Global Management Common (APO)
Alphabet Inc-Cl C Common (GOOG)
Janus Henderson AAA CLO ETF Common (JAAA)
Darling Ingredients Common Call Option (DAR)
Xeris Biopharma Holdings Common (XERS)
Syndax Pharmaceutical Common (SNDX)
JPMorgan Chase & Co. Common (JPM)
Travere Therapeutics Common (TVTX)
Avadel Pharmaceuticals Common (AVDL)
Protagonist Therapeutics Common (PTGX)
Bridgebio Pharma Common (BBIO)
DocGo Common (DCGO)
Verona Pharma Common (VRNA)
LENZ Therapeutics Common (LENZ)

View all positions for Knott David M Jr

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
FMR
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Sands Capital Management
Rtw Investments
Baker Bros. Advisors
Suvretta Capital Management
Wellington Management Company
Bnp Paribas Investment Partners
Geode Capital Management
Jacobs Levy Equity Management
Standard Life Aberdeen
Jennifer Ranahan

View all funds holding Ultragenyx Pharmaceutical